Is human platelet lysate (hPL) the ideal candidate to substitute the foetal bovine serum for cell-therapy translational research?
Crossref DOI link: https://doi.org/10.1186/s12967-021-03104-w
Published Online: 2021-10-13
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guiotto, M. http://orcid.org/0000-0002-2019-002X
Riehle, M. O.
Raffoul, W.
Hart, A.
di Summa, P. G.
Funding for this research was provided by:
Fondation Leenaards
Text and Data Mining valid from 2021-10-13
Version of Record valid from 2021-10-13
Article History
Received: 12 September 2021
Accepted: 1 October 2021
First Online: 13 October 2021
Declarations
:
: Not applicable.
: None.